307 related articles for article (PubMed ID: 15231873)
1. Plasma membrane estrogen receptors exist and functions as dimers.
Razandi M; Pedram A; Merchenthaler I; Greene GL; Levin ER
Mol Endocrinol; 2004 Dec; 18(12):2854-65. PubMed ID: 15231873
[TBL] [Abstract][Full Text] [Related]
2. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells.
Razandi M; Pedram A; Greene GL; Levin ER
Mol Endocrinol; 1999 Feb; 13(2):307-19. PubMed ID: 9973260
[TBL] [Abstract][Full Text] [Related]
3. Nature of functional estrogen receptors at the plasma membrane.
Pedram A; Razandi M; Levin ER
Mol Endocrinol; 2006 Sep; 20(9):1996-2009. PubMed ID: 16645038
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
6. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane.
Razandi M; Alton G; Pedram A; Ghonshani S; Webb P; Levin ER
Mol Cell Biol; 2003 Mar; 23(5):1633-46. PubMed ID: 12588983
[TBL] [Abstract][Full Text] [Related]
7. Binding of estrogen receptor beta to estrogen response element in situ is independent of estradiol and impaired by its amino terminus.
Huang J; Li X; Maguire CA; Hilf R; Bambara RA; Muyan M
Mol Endocrinol; 2005 Nov; 19(11):2696-712. PubMed ID: 15976006
[TBL] [Abstract][Full Text] [Related]
8. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol: role of ERalpha domains with known nuclear functions.
Chambliss KL; Simon L; Yuhanna IS; Mineo C; Shaul PW
Mol Endocrinol; 2005 Feb; 19(2):277-89. PubMed ID: 15486047
[TBL] [Abstract][Full Text] [Related]
10. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
12. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
[TBL] [Abstract][Full Text] [Related]
13. Requirements for estrogen receptor alpha membrane localization and function.
Evinger AJ; Levin ER
Steroids; 2005; 70(5-7):361-3. PubMed ID: 15862818
[TBL] [Abstract][Full Text] [Related]
14. Classical genotropic versus kinase-initiated regulation of gene transcription by the estrogen receptor alpha.
Almeida M; Han L; O'brien CA; Kousteni S; Manolagas SC
Endocrinology; 2006 Apr; 147(4):1986-96. PubMed ID: 16384865
[TBL] [Abstract][Full Text] [Related]
15. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
18. Growth factors change nuclear distribution of estrogen receptor-alpha via mitogen-activated protein kinase or phosphatidylinositol 3-kinase cascade in a human breast cancer cell line.
Takahashi T; Ohmichi M; Kawagoe J; Ohshima C; Doshida M; Ohta T; Saitoh M; Mori-Abe A; Du B; Igarashi H; Takahashi K; Kurachi H
Endocrinology; 2005 Sep; 146(9):4082-9. PubMed ID: 15947004
[TBL] [Abstract][Full Text] [Related]
19. 17β-estradiol Induces MMP-9 and MMP-13 in TMJ Fibrochondrocytes via Estrogen Receptor α.
Ahmad N; Chen S; Wang W; Kapila S
J Dent Res; 2018 Aug; 97(9):1023-1030. PubMed ID: 29621430
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]